Anthony Collias

Anthony Collias has a diverse work experience in the medical technologies industry. Anthony started their career at Biocompatibles Ltd in 1997 as an R&D project leader before transitioning into roles as Marketing and Clinical Support Manager. Anthony then joined Abbott Vascular Devices in 2002 as a Marketing Manager for Cardiovascular EMEA, where they supported direct sales organizations and distributors across Europe, Middle East, and Africa in growing Abbott Vascular's footprint. Anthony was awarded Marketing Manager of the Year in 2004. In 2004, Collias moved to Sorin Group as a Marketing Manager for Drug Eluting Stents, eventually becoming the Global Marketing Director for the Vascular Therapies franchise. During their time at Sorin Group, they led the development and commercial roll-out of the 3rd Drug Eluting Stent to be granted CE mark. In 2007, they joined Abbott Spine as the Marketing Director, International. Collias then joined Zimmer in 2008, starting as the Director of Marketing for Spine EMEA, before progressing to the roles of Director of Sales & Marketing and Managing Director for Spine EMEA. Their achievements at Zimmer include expanding the Zimmer Spine footprint across EMEA and broadening the portfolio offering to reach over 50M$. In 2017, Collias founded Medical Technologies Consulting, where they worked as the Director and Founder. Anthony most recently joined Aerobiotix, Inc. in 2018 as the General Manager for EMEA.

Anthony Collias completed their education at three different institutions. In 1994, they attended The University of Huddersfield and studied Chemistry and Business Management for a year. From 1995 to 1997, they then pursued a Maitrise Sciences et Techniques degree in Fine Chemicals at Aix-Marseille University. Later, from 2003 to 2005, they attended The Open University Business School where they earned a Master of Business Administration (MBA) degree specializing in Business and Administration.